HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

meglumine antimoniate

used in treatment of leishmaniasis
Also Known As:
Aventis brand of meglumine antimoniate; Glucantime; N-methylglucamine antimonate; 1-deoxy-1- (methylamino)glucitol antimonate(V)
Networked: 344 relevant articles (52 outcomes, 45 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Frézard, Frédéric: 11 articles (10/2014 - 01/2004)
2. Demicheli, Cynthia: 9 articles (10/2014 - 01/2004)
3. Khamesipour, Ali: 9 articles (09/2014 - 01/2005)
4. Schubach, Armando de Oliveira: 6 articles (01/2015 - 05/2005)
5. Mohebali, M: 6 articles (02/2012 - 07/2007)
6. Layegh, Pouran: 5 articles (12/2015 - 07/2007)
7. Ribeiro, Raul R: 5 articles (10/2014 - 06/2006)
8. Khatami, Alireza: 5 articles (01/2014 - 01/2005)
9. Firooz, Alireza: 5 articles (01/2013 - 01/2005)
10. Moghiman, Toktam: 4 articles (12/2015 - 07/2007)

Related Diseases

1. Cutaneous Leishmaniasis
2. Leishmaniasis
3. Visceral Leishmaniasis (Kala Azar)
4. Infection
5. Cicatrix (Scar)

Related Drugs and Biologics

1. meglumine antimoniate
2. Allopurinol (Remid)
3. Paromomycin (Paromomycin Sulfate)
4. Liposomes (Liposome)
5. Antimony Sodium Gluconate (Sodium, Stibogluconate)
6. Meglumine
7. Pentamidine (NebuPent)
8. Ketoconazole (Nizoral)
9. Carbon Monoxide
10. imiquimod (Aldara)

Related Therapies and Procedures

1. Intralesional Injections
2. Cryotherapy (Therapy, Cold)
3. Immunotherapy
4. Lasers (Laser)
5. Drug Therapy (Chemotherapy)